Log In
Print
BCIQ
Print
Print this Print this
 

ASP7035

  Manage Alerts
Collapse Summary General Information
Company Tacurion Pharma Inc.
DescriptionVasopressin 2 (V2) receptor agonist
Molecular Target Vasopressin 2 (V2) receptor
Mechanism of ActionVasopressin 2 (V2) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Genitourinary (unspecified)
Indication DetailsTreat nocturia
Regulatory Designation

Partner

Drais Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today